Alk-Abello AS (WBO:ALKB) Construction In Progress: €73.3 Mil (As of Mar. 2026)


WBO:ALKB Alk-Abello AS WBO:ALKB
66 GF Score
Price €34.22
GF Value €27.26
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Alk-Abello AS Construction In Progress?

Alk-Abello AS WBO:ALKB -0.12% 66 Construction In Progress is €73.3 Mil as of Mar. 2026. GuruFocus rates WBO:ALKB with a GF Score™ of 66/100 and a GF Value™ of €27.26 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Alk-Abello AS's quarterly construction in progress increased from Sep. 2025 (€63.5 Mil) to Dec. 2025 (€70.2 Mil) and increased from Dec. 2025 (€70.2 Mil) to Mar. 2026 (€73.3 Mil).

Alk-Abello AS's annual construction in progress declined from Dec. 2023 (€80.0 Mil) to Dec. 2024 (€70.8 Mil) and declined from Dec. 2024 (€70.8 Mil) to Dec. 2025 (€70.2 Mil).

Alk-Abello AS Construction In Progress Historical Data

* Premium members only.

The historical data trend for Alk-Abello AS's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alk-Abello AS Construction In Progress Chart

Alk-Abello AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.71 68.69 79.96 70.80 70.16

Alk-Abello AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.03 56.70 63.51 70.16 73.32
WBO:ALKB
66GF Score
Alk-Abello AS WBO:ALKB
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alk-Abello AS Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of €73.3 Mil mean?
Alk-Abello AS (WBO:ALKB) has a Construction In Progress of €73.3 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Alk-Abello AS and its competitors.
Is Alk-Abello AS's Construction In Progress too high?
Alk-Abello AS's current Construction In Progress is €73.3 Mil. Overall, Alk-Abello AS has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Construction In Progress compare to VRTX and REGN?
Alk-Abello AS's Construction In Progress of €73.3 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Alk-Abello AS and its competitors. Alk-Abello AS's current Construction In Progress is €73.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (WBO:ALKB) is currently considered Modestly Overvalued. The stock's GF Value™ is €27.26, compared to a current price of €34.22 — trading 25.5% above its estimated fair value. The current Construction In Progress is €73.3 Mil. Alk-Abello AS's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Alk-Abello AS (WBO:ALKB), the current Construction In Progress is €73.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alk-Abello AS (WBO:ALKB) Overvalued in 2026?

Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued. The current stock price of €34.22 is trading 25.5% above its estimated GF Value™ of €27.26. GuruFocus considers Alk-Abello AS to be Modestly Overvalued.

Key valuation signals for WBO:ALKB:

  • Construction In Progress: €73.3 Mil
  • GF Value™: €27.26 vs. price of €34.22 (25.5% above fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the WBO:ALKB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alk-Abello AS Business Description

Address Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
66GF Score

Get the complete analysis for WBO:ALKB

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€34.22
Price
€27.26
GF Value